Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00857389
Title Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

non-Hodgkin lymphoma

acute myeloid leukemia

chronic lymphocytic leukemia

bone marrow cancer

acute lymphoblastic leukemia

Hodgkin's lymphoma

chronic myeloid leukemia

Therapies

Cyclophosphamide

Filgrastim

Tacrolimus

Thiotepa

anti-thymocyte globulin + Busulfan + Clofarabine

Methotrexate

Age Groups: adult
Covered Countries USA


No variant requirements are available.